Realta Investment Advisors’s ETF Series Solutions Trust Range Cancer Therapeutics ETF CNCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-539
| Closed | -$7.28K | – | 411 |
|
|
2024
Q2 | $7.28K | Hold |
539
| – | – | ﹤0.01% | 695 |
|
|
2024
Q1 | $8.96K | Buy |
+539
| New | +$8.96K | ﹤0.01% | 707 |
|
|
2023
Q4 | – | Sell |
-539
| Closed | -$6.96K | – | 485 |
|
|
2023
Q3 | $6.96K | Hold |
539
| – | – | ﹤0.01% | 697 |
|
|
2023
Q2 | $6.96K | Buy |
+539
| New | +$6.96K | ﹤0.01% | 743 |
|
|
2023
Q1 | – | Sell |
-539
| Closed | -$7.4K | – | 471 |
|
|
2022
Q4 | $7.4K | Hold |
539
| – | – | ﹤0.01% | 741 |
|
|
2022
Q3 | $8K | Buy |
+539
| New | +$8K | ﹤0.01% | 713 |
|
|
2020
Q1 | – | Sell |
-539
| Closed | -$13K | – | 494 |
|
|
2019
Q4 | $13K | Buy |
+539
| New | +$13K | ﹤0.01% | 1059 |
|